Showing 13,781 - 13,800 results of 50,908 for search '(( a ((mean decrease) OR (linear decrease)) ) OR ( a ((latent decrease) OR (larger decrease)) ))', query time: 1.15s Refine Results
  1. 13781
  2. 13782

    Effect of mutations on neutralization by antibodies elicited by 2x BNT162b2 vaccination, Delta breakthrough after 2x mRNA vaccination, or primary Delta infection. by Allison J. Greaney (11046384)

    Published 2022
    “…Points represent the geometric mean across cohorts (NT50s plotted in (A)). Error bars represent geometric standard deviation. …”
  3. 13783
  4. 13784
  5. 13785
  6. 13786
  7. 13787

    Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization by Ozdemir Ozdemir (5762834)

    Published 2018
    “…Conclusions: This study demonstrates that both subconjunctival and topical administrations of bevacizumab inhibit corneal neovascularization and decrease inflammation and fibroblast activity in a rat model of corneal neovascularization induced by alkali burn.…”
  8. 13788
  9. 13789
  10. 13790
  11. 13791
  12. 13792
  13. 13793
  14. 13794
  15. 13795

    Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells by Heather E. Wheeler (174954)

    Published 2015
    “…We show the potential of the model for gene perturbation studies by demonstrating decreased expression of <i>TUBB2A</i> results in significantly increased sensitivity of neurons to paclitaxel (0.23 ± 0.06 decrease in total neurite outgrowth, P = 0.011). …”
  16. 13796
  17. 13797
  18. 13798
  19. 13799

    Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco by Albert Y. Liu (207707)

    Published 2011
    “…In the longitudinal analysis, there was a 1.1% net decrease in mean BMD in the TDF vs. the pre-treatment/placebo group at the femoral neck (95% CI 0.4–1.9%), 0.8% net decline at the total hip (95% CI 0.3–1.3%), and 0.7% at the L2–L4 spine (95% CI −0.1–1.5%). …”
  20. 13800